查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1751020

2025年全球人类类器官市场报告

Human Organoids Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年人类类器官市场规模将快速成长。 2029年，该市场规模将成长至31.5亿美元，复合年增长率为16.5%。预测期内的增长归因于对基于类器官的疾病建模需求的不断增长、生物技术研究投入的不断增加、药物筛检应用的不断扩展、毒理学研究应用的日益普及以及对精准医疗日益增长的兴趣。预测期内的主要趋势包括人工智慧的整合、患者特异性类器官的开发、基因治疗应用的扩展、类器官生物列印的进步以及3D细胞培养技术的进步。

预计基因研究实验的增加将推动研究市场的成长。基因科学关注性状如何透过基因遗传以及遗传讯息如何影响生物体的发育和功能，由于技术进步使得基因编辑更快、更精确，实验数量正在增加。这些突破使得对疾病的研究更加深入和开发有针对性的治疗方法成为可能。在人体类器官的背景下，基因科学可以精确地操纵基因来模拟特定疾病并研究其进展。这有助于研究人员更了解遗传疾病、测试新药并探索个人化治疗策略。例如，根据美国医学研究机构国立卫生研究院 (NIH) 2023 年 4 月的报告，截至 2022 年 11 月，美国共註册了 129,624 项基因测试，约占全球基因测试註册中心 (GTR) 註册的所有测试的 66%。因此，基因研究实验数量的增加将有助于人体类器官市场的成长。

为了提高体外模型的生理相关性，人类类器官市场的主要企业正专注于开发先进的干细胞技术，例如新一代3D组织培养平台。新一代3D组织培养平台是先进的体外系统，旨在比传统的2D和早期的3D模型更准确地再现人体组织的复杂性。例如，2022年10月，AIM Biotech Pte. Ltd.推出了先进的3D组织培养系统organiX。该系统旨在透过整合类器官、功能性血管系统和免疫细胞成分，更准确地再现人类疾病状况。该平台专为尖端药物开发和个人化医疗量身定制，可在可控且生理相关的环境中容纳各种组织形式，包括类器官和肿瘤样本。它支援免疫共培养，实现即时高解析度成像，并有助于组织恢復以供下游分析。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人类类器官 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球人体类器官市场：成长率分析
  • 全球人体类器官市场表现：规模与成长，2019-2024
  • 全球人体类器官市场预测：2024-2029年及2034年规模与成长
  • 全球人类类器官总目标市场（TAM）

第六章市场区隔

  • 全球人体类器官市场类型、表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 脑类器官
  • 心臟类器官
  • 肠道类器官
  • 肾臟类器官
  • 肝臟类器官
  • 肺类器官
  • 胰臟类器官
  • 全球人体类器官市场（按技术、性能和预测）：2019-2024 年、2024-2029 年、2034 年
  • 3D生物列印
  • 细胞培养技术
  • 水凝胶和基于支架的技术
  • 磁浮
  • 全球人体类器官市场：应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 药物研发
  • 感染疾病监测
  • 神经学研究
  • 肿瘤监测
  • 个人化医疗
  • 再生医学
  • 全球人体类器官市场：依最终使用者、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 製药和生物技术公司
  • 合约研究组织
  • 学术研究所
  • 全球人类类器官市场脑类器官细分（依类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 脑类器官
  • 中脑类器官
  • 下视丘类器官
  • 脊髓类器官
  • 全球人体类器官市场心臟类器官细分（依类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 心臟类器官
  • 血管化心臟类器官
  • 心室特异性心臟类器官
  • 全球人体类器官市场肠道类器官细分（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 小肠类器官
  • 结肠类器官
  • 十二指肠类器官
  • 全球人体类器官市场肾臟类器官细分（依类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 肾元类器官
  • 肾丝球类器官
  • 近端小管类器官
  • 全球人体类器官市场肝臟类器官细分（依类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 肝臟类器官
  • 胆管类器官
  • 胆管细胞类器官
  • 全球人体类器官市场肺类器官细分（依类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 气道类器官
  • 肺泡类器官
  • 支气管类器官
  • 全球人体类器官市场：胰臟类器官细分（按类型、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 胰岛类器官
  • 管状胰臟类器官
  • 胰腺腺泡类器官

第七章 区域和国家分析

  • 全球人体类器官市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球人体类器官市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 人体类器官市场：竞争格局
  • 人体类器官市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Emulate Inc.
  • MIMETAS BV
  • Cellink AB
  • InSphero AG
  • Kerafast Inc.
  • DefiniGEN Limited
  • Visikol Inc.
  • CN Bio Innovations Limited
  • Cannex Scientific Inc.
  • HeartBeat.bio AG
  • Kirkstall Ltd.
  • Cyprio Ltd.
  • 3Dnamics Inc.
  • BrainZell Ltd.
  • AIVITA Biomedical Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年人类类器官市场：提供新机会的国家
  • 2029年人类类器官市场：细分领域蕴含新机会
  • 2029年人体类器官市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r34873

Human organoids are powerful models for studying human biology, disease mechanisms, and testing drug responses in ways that mimic real human organs. The main types of human organoids, such as brain, heart, intestinal, kidney, liver, lung, and pancreatic organoids, allow researchers to investigate specific organ-related diseases and conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Brain organoids, for instance, are used in drug discovery, neurology studies, infectious disease research, oncology research, and personalized medicine. These organoids are created using cutting-edge technologies, such as 3D bioprinting, hydrogels, scaffold-based methods, and magnetic levitation, which help replicate the three-dimensional structure and function of human tissues. The primary users of these organoids include pharmaceutical and biotechnology companies, contract research organizations (CROs), and academic research institutions, which use these models for various applications ranging from disease modeling to drug testing and personalized therapeutic development.

The human organoids market research report is one of a series of new reports from The Business Research Company that provides human organoids market statistics, including human organoids industry global market size, regional shares, competitors with a human organoids market share, detailed human organoids market segments, market trends and opportunities, and any further data you may need to thrive in the human organoids industry. This human organoids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human organoids market size has grown rapidly in recent years. It will grow from $1.47 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 16.8%. The growth during the historic period can be attributed to a greater emphasis on personalized medicine, the rising prevalence of chronic diseases, advancements in regenerative medicine, the expansion of drug discovery applications, and the increase in government and private sector funding.

The human organoids market size is expected to see rapid growth in the next few years. It will grow to $3.15 billion in 2029 at a compound annual growth rate (CAGR) of 16.5%. The growth during the forecast period can be attributed to the rising demand for organoid-based disease modeling, increased investment in biotech research, expanding uses in drug screening, greater adoption in toxicology studies, and growing interest in precision medicine. Key trends in the forecast period include the integration of artificial intelligence, the development of patient-specific organoids, expansion into gene therapy applications, advancements in organoid bioprinting, and technological progress in 3D cell culture.

The growing number of genetic research experiments is expected to drive the growth of the human organoids market. Genetic science, which focuses on how traits are inherited through genes and how genetic information influences the development and functioning of organisms, is seeing an increase in experiments due to technological advancements that make gene editing faster and more accurate. These breakthroughs enable deeper research into diseases and the development of targeted treatments. In the context of human organoids, genetic science allows for precise manipulation of genes to model specific diseases and study their progression. This helps researchers better understand genetic disorders, test new drugs, and explore personalized treatment strategies. For example, in April 2023, a report by the National Institutes of Health (NIH), a US-based medical research agency, noted that by November 2022, the U.S. had registered 129,624 genetic tests, accounting for approximately 66% of all tests in the worldwide Genetic Testing Registry (GTR). As such, the rising number of genetic research experiments will contribute to the growth of the human organoids market.

Leading companies in the human organoids market are focusing on developing advanced stem cell technologies, such as next-generation 3D tissue culture platforms, to enhance the physiological relevance of in vitro models. A next-generation 3D tissue culture platform is an advanced in vitro system designed to more accurately replicate the complexity of human tissues compared to traditional 2D or earlier 3D models. For instance, in October 2022, AIM Biotech Pte. Ltd., a Singapore-based developer of tissue culture chips, introduced organiX, an advanced 3D tissue culture system. This system is designed to more accurately replicate human disease conditions by integrating organoids, functional vasculature, and immune cell components. The platform is tailored for cutting-edge drug development and personalized medicine, accommodating various tissue formats, such as organoids and tumor samples, within a controllable and physiologically relevant environment. It supports immune co-culture, allows real-time high-resolution imaging, and facilitates easy tissue retrieval for downstream analyses.

In January 2025, Merck Group, a Germany-based pharmaceutical company, acquired HUB Organoids Holding B.V. for an undisclosed amount. This acquisition aims to bolster Merck's next-generation biology portfolio by incorporating advanced organoid technology. This will accelerate drug development, provide deeper insights into treatments across various populations, and reduce the need for animal testing, aligning with Merck's commitment to innovative and ethical life sciences solutions. HUB Organoids Holding B.V., based in the Netherlands, specializes in human organoid research and applications.

Major players in the human organoids market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Corning Incorporated, Bio-Techne Corporation, Organovo Holdings Inc., Emulate Inc., MIMETAS B.V., Cellink AB, InSphero AG, Kerafast Inc., DefiniGEN Limited, Visikol Inc., CN Bio Innovations Limited, Cannex Scientific Inc., HeartBeat.bio AG, Kirkstall Ltd., Cyprio Ltd., 3Dnamics Inc., BrainZell Ltd., AIVITA Biomedical Inc.

North America was the largest region in the human organoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human organoids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the human organoids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human organoids market include revenues earned by entities by providing services such as drug discovery and development, disease modeling, toxicology testing, regenerative medicine research, and biomarker discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. The human organoids market also consists of sales of products including organoid-based therapeutics, disease modeling solutions, drug testing platforms, and research applications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Organoids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on human organoids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human organoids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human organoids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Brain Organoids; Heart Organoids; Intestinal Organoids; Kidney Organoids; Liver Organoids; Lung Organoids; Pancreatic Organoids
  • 2) By Technology: 3D Bioprinting; Cell Culture Technology; Hydrogels And Scaffold-Based Technology; Magnetic Levitation
  • 3) By Application: Drug Discovery; Infectious Disease Research; Neurology Studies; Oncology Research; Personalized Medicine; Regenerative Medicine
  • 4) By End User: Pharma And Biotech Companies; Contract Research Organizations; Academic And Research Institutes
  • Subsegments:
  • 1) By Brain Organoids: Cerebral Organoids; Midbrain Organoids; Hypothalamic Organoids; Spinal Cord Organoids
  • 2) By Heart Organoids: Cardiac Muscle Organoids; Vascularized Heart Organoids; Chamber-Specific Heart Organoids
  • 3) By Intestinal Organoids: Small Intestine Organoids; Colon Organoids; Duodenal Organoids
  • 4) By Kidney Organoids: Nephron Organoids; Glomerular Organoids; Proximal Tubule Organoids
  • 5) By Liver Organoids: Hepatic Organoids; Bile Duct Organoids; Cholangiocyte Organoids
  • 6) By Lung Organoids: Airway Organoids; Alveolar Organoids; Bronchial Organoids
  • 7) By Pancreatic Organoids: Islet Organoids; Ductal Pancreatic Organoids; Acinar Pancreatic Organoids
  • Companies Mentioned: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Corning Incorporated; Bio-Techne Corporation; Organovo Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Human Organoids Market Characteristics

3. Human Organoids Market Trends And Strategies

4. Human Organoids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Human Organoids Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Human Organoids PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Human Organoids Market Growth Rate Analysis
  • 5.4. Global Human Organoids Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Human Organoids Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Human Organoids Total Addressable Market (TAM)

6. Human Organoids Market Segmentation

  • 6.1. Global Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Brain Organoids
  • Heart Organoids
  • Intestinal Organoids
  • Kidney Organoids
  • Liver Organoids
  • Lung Organoids
  • Pancreatic Organoids
  • 6.2. Global Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 3D Bioprinting
  • Cell Culture Technology
  • Hydrogels And Scaffold-Based Technology
  • Magnetic Levitation
  • 6.3. Global Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery
  • Infectious Disease Research
  • Neurology Studies
  • Oncology Research
  • Personalized Medicine
  • Regenerative Medicine
  • 6.4. Global Human Organoids Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharma And Biotech Companies
  • Contract Research Organizations
  • Academic And Research Institutes
  • 6.5. Global Human Organoids Market, Sub-Segmentation Of Brain Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cerebral Organoids
  • Midbrain Organoids
  • Hypothalamic Organoids
  • Spinal Cord Organoids
  • 6.6. Global Human Organoids Market, Sub-Segmentation Of Heart Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Muscle Organoids
  • Vascularized Heart Organoids
  • Chamber-Specific Heart Organoids
  • 6.7. Global Human Organoids Market, Sub-Segmentation Of Intestinal Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Small Intestine Organoids
  • Colon Organoids
  • Duodenal Organoids
  • 6.8. Global Human Organoids Market, Sub-Segmentation Of Kidney Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nephron Organoids
  • Glomerular Organoids
  • Proximal Tubule Organoids
  • 6.9. Global Human Organoids Market, Sub-Segmentation Of Liver Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hepatic Organoids
  • Bile Duct Organoids
  • Cholangiocyte Organoids
  • 6.10. Global Human Organoids Market, Sub-Segmentation Of Lung Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Airway Organoids
  • Alveolar Organoids
  • Bronchial Organoids
  • 6.11. Global Human Organoids Market, Sub-Segmentation Of Pancreatic Organoids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Islet Organoids
  • Ductal Pancreatic Organoids
  • Acinar Pancreatic Organoids

7. Human Organoids Market Regional And Country Analysis

  • 7.1. Global Human Organoids Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Human Organoids Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Human Organoids Market

  • 8.1. Asia-Pacific Human Organoids Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Human Organoids Market

  • 9.1. China Human Organoids Market Overview
  • 9.2. China Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Human Organoids Market

  • 10.1. India Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Human Organoids Market

  • 11.1. Japan Human Organoids Market Overview
  • 11.2. Japan Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Human Organoids Market

  • 12.1. Australia Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Human Organoids Market

  • 13.1. Indonesia Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Human Organoids Market

  • 14.1. South Korea Human Organoids Market Overview
  • 14.2. South Korea Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Human Organoids Market

  • 15.1. Western Europe Human Organoids Market Overview
  • 15.2. Western Europe Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Human Organoids Market

  • 16.1. UK Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Human Organoids Market

  • 17.1. Germany Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Human Organoids Market

  • 18.1. France Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Human Organoids Market

  • 19.1. Italy Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Human Organoids Market

  • 20.1. Spain Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Human Organoids Market

  • 21.1. Eastern Europe Human Organoids Market Overview
  • 21.2. Eastern Europe Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Human Organoids Market

  • 22.1. Russia Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Human Organoids Market

  • 23.1. North America Human Organoids Market Overview
  • 23.2. North America Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Human Organoids Market

  • 24.1. USA Human Organoids Market Overview
  • 24.2. USA Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Human Organoids Market

  • 25.1. Canada Human Organoids Market Overview
  • 25.2. Canada Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Human Organoids Market

  • 26.1. South America Human Organoids Market Overview
  • 26.2. South America Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Human Organoids Market

  • 27.1. Brazil Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Human Organoids Market

  • 28.1. Middle East Human Organoids Market Overview
  • 28.2. Middle East Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Human Organoids Market

  • 29.1. Africa Human Organoids Market Overview
  • 29.2. Africa Human Organoids Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Human Organoids Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Human Organoids Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Human Organoids Market Competitive Landscape And Company Profiles

  • 30.1. Human Organoids Market Competitive Landscape
  • 30.2. Human Organoids Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Corning Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Human Organoids Market Other Major And Innovative Companies

  • 31.1. Emulate Inc.
  • 31.2. MIMETAS B.V.
  • 31.3. Cellink AB
  • 31.4. InSphero AG
  • 31.5. Kerafast Inc.
  • 31.6. DefiniGEN Limited
  • 31.7. Visikol Inc.
  • 31.8. CN Bio Innovations Limited
  • 31.9. Cannex Scientific Inc.
  • 31.10. HeartBeat.bio AG
  • 31.11. Kirkstall Ltd.
  • 31.12. Cyprio Ltd.
  • 31.13. 3Dnamics Inc.
  • 31.14. BrainZell Ltd.
  • 31.15. AIVITA Biomedical Inc.

32. Global Human Organoids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Human Organoids Market

34. Recent Developments In The Human Organoids Market

35. Human Organoids Market High Potential Countries, Segments and Strategies

  • 35.1 Human Organoids Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Human Organoids Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Human Organoids Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250617_r34873_Human_Organoids_GMR_2025